The Accomplishments of Dr. Scott Rocklage in Healthcare Sector.

Whenever people speak about success in the field of Healthcare, one name always comes up, Dr. Scott M Rocklage. When joining 5 AM Ventures in 2003, Dr. Scott M Rocklage joined as a partner but later became the company’s managing partner. He has built a name for himself with his outstanding strategic leadership skills, hard work, ambition, and by inspiring and mentoring many doctors. Dr. Scott Rocklage graduated with a B.S in Chemistry from the University of California, Berkely, and later joined Massuchetts Institute of Technology, where he did his Ph.D. in Chemistry.

Many people embraced Dr. Scott Rocklage biggest achievement when he advocated for the approval of three major drug applications in the United States. These drugs are Omniscan TM, Teslescan, and Cubicin. While he was doing his Ph.D., Scott was able to conduct research on Richard R .Schrocks, a Nobel Prize winner Laboratory. Rockledge has also worked with various pharmaceutical industries where he devoted his time and resources to see the companies grow and provide quality services. Scott worked with Cubist Pharmaceutical, NASDAQ: RLP among many others. He is also an inventor of quite many U.S patents and numerous publications and more information click here.

Dr. Rocklage has an extensive experience in the health sector, which he has acquired from various companies that he has worked with, both in the management team and as an employee. Before joining 5 AM, Dr. Rocklage served as Chief Executive Officer, President, and Chairman of Nycomed Interventional, Inc., from the year 1992 to 1994. He worked with Cubist Pharmaceuticals Inc, as a president from July 1994 to March 2001. He also worked as a founding Chief Executive Officer of the same company from July 1994 to June 2003. Dr. Scott Rocklage has founded and co-founded many successful firms where his achievements and support will always be remembered and Scott’s lacrosse camp.

More visit: http://www.rennovia.com/team/scott-m-rocklage/

Leave a Reply

Your email address will not be published. Required fields are marked *